期刊文献+

The dehydration behavior and non-isothermal dehydration kinetics of donepezil hydrochloride monohydrate (Form I)

The dehydration behavior and non-isothermal dehydration kinetics of donepezil hydrochloride monohydrate (Form I)
原文传递
导出
摘要 Powders of donepezil hydrochloride monohy- drate (Form I) underwent isomorphic dehydration, losing 3% w/w water between 90% and 10% relative humidity (RH) without changing its powder X-ray pattern. Below 10% RH, additional dehydration occurred in conjunction with a reversible phase transition between the monohy- drate state and a dehydrated state, with a 4.0% w/w loss to 0% RH. A combination of methods was used to understand the structural changes occurring during the desolvation process, including dynamic vapor sorption measurements, thermal analysis and powder X-ray diffraction. Form I showed the characteristics of the channel hydrate, whose non-isothermal dehydration behavior proceeds in two steps: (1) the loss of non-crystalline water adsorbed on the surface, and (2) the loss of one crystalline water in the channel. Dehydrated Form I is structurally similar to the monohydrate Form I. According to the heat of fusion and the crystal density criteria, the two crystal forms belonged to the univariant system, and the anhydrate (Form III) is stable. The dehydration kinetics was achieved from the TG-DTG curves by both the Achar method and the Coats- Redfern method with 15 frequently cited basic kinetic models. The dynamic dehydration processes for steps 1 and 2 were best expressed by the Zhuralev-Lesokin- Tempelman equation, suggesting a three-dimensional diffusion-controlled mechanism. Powders of donepezil hydrochloride monohy- drate (Form I) underwent isomorphic dehydration, losing 3% w/w water between 90% and 10% relative humidity (RH) without changing its powder X-ray pattern. Below 10% RH, additional dehydration occurred in conjunction with a reversible phase transition between the monohy- drate state and a dehydrated state, with a 4.0% w/w loss to 0% RH. A combination of methods was used to understand the structural changes occurring during the desolvation process, including dynamic vapor sorption measurements, thermal analysis and powder X-ray diffraction. Form I showed the characteristics of the channel hydrate, whose non-isothermal dehydration behavior proceeds in two steps: (1) the loss of non-crystalline water adsorbed on the surface, and (2) the loss of one crystalline water in the channel. Dehydrated Form I is structurally similar to the monohydrate Form I. According to the heat of fusion and the crystal density criteria, the two crystal forms belonged to the univariant system, and the anhydrate (Form III) is stable. The dehydration kinetics was achieved from the TG-DTG curves by both the Achar method and the Coats- Redfern method with 15 frequently cited basic kinetic models. The dynamic dehydration processes for steps 1 and 2 were best expressed by the Zhuralev-Lesokin- Tempelman equation, suggesting a three-dimensional diffusion-controlled mechanism.
出处 《Frontiers of Chemical Science and Engineering》 SCIE EI CAS CSCD 2014年第1期55-63,共9页 化学科学与工程前沿(英文版)
关键词 DEHYDRATION thermal analysis transformation dehydration kinetics dehydration, thermal analysis, transformation,dehydration kinetics
  • 相关文献

参考文献31

  • 1Han J, Gupte S, Suryanarayanan R. Applications of pressure differential scanning calorimetry in the study of pharmaceutical hydrates. II. Ampicillin trihydrate. International Journal of Pharma- ceutics, 1998, 170(1): 63-72.
  • 2Krzyzaniak J F, Williams G R, Ni N. Identification of phase boundaries in anhydrate/hydrate systems. Journal of Pharmaceutical Sciences, 2007, 96(5): 1270-1281.
  • 3Khankari R K, Grant D J W. Pharmaceutical hydrates. Thermo- chimica Acta, 1995, 248(0): 61-69.
  • 4Wang S L, Wong Y C, Cheng W T, Lin S Y. A continuous process for solid-state dehydration, amorphization and recrystallization of metoclopramide HCL monohydrate studied by simultaneous DSC- FTIR microspeetroscopy. Journal of Thermal Analysis and Calorimetry, 2011, 104(1): 261- 264.
  • 5Bym S R, Xu W, Newman A W. Chemical reactivity in solid-state pharmaceuticals: formulation implications. Advanced Drug Deliv- ery Reviews, 2001, 48(1): 115-136.
  • 6Gamier S, Petit S, Coquerel G. Dehydration mechanism and crystallisation behaviour of lactose. Journal of Thermal Analysis and Calorimetry, 2002, 68(2): 489 -502.
  • 7Legendre B, Baziard-Mouysset G, Anastassiadou M, Leger J M, Payard A. Polymorphic study of 2-(2-benzofuryl) Delta-2 imidazo- line. Journal of Thermal Analysis and Calorimetry, 2001, 66(2): 659-673.
  • 8Willart J F, Descamps M. Solid State Amorphization of Pharma- ceuticals. Molecular Pharmaceutics, 2008, 5(6): 905- 920.
  • 9Byrn S R, Pfeiffer R R, Stephenson G, Grant D J W, Gleason W B. Solid-State Pharmaceutical Chemistry. Chemistry of Materials, 1994. 6(8): 1148-1158.
  • 10Vippagunta S R, Brittain H G, Grant D J W. Crystalline solids. Advanced Drug Delivery Reviews, 2001, 48(1): 3 -26 S.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部